Cenobamate
Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy
SK Life Science, Inc.Small moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy cohort.
Same molecule, other indications
Cenobamate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →